Provoked seizures are not considered to be epilepsy, which is defined as two or more unprovoked seizures, and provoked seizures typically do not require long-term treatment with antiseizure medication ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Keeping newborns on antiseizure medication after acute neonatal ...
SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious ...
(RTTNews) - CeriBell, Inc. (CBLL) announces that the U.S. FDA has granted 510(k) clearance for its next-generation Clarity algorithm to detect electrographic seizures in preterm neonates through ...
Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology. “Many ...
Philadelphia, March 22, 2023 – Researchers from the Neuroscience Center at Children’s Hospital of Philadelphia (CHOP) have developed a prediction model that determines which newborn babies are likely ...
SUNNYVALE, Calif. - CeriBell, Inc. (NASDAQ:CBLL) announced Monday that the U.S. Food and Drug Administration has granted 510(k) clearance for its next-generation Clarity algorithm to detect ...
Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies SUNNYVALE, Calif., ...
Investing.com -- CeriBell Inc (NASDAQ:CBLL) stock rose 2.2% in premarket trading Monday after the medical technology company announced FDA clearance for its AI-powered seizure detection algorithm for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback